TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Roche Pharmaceuticals A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
102,164
|
211,284
|
98,548 |
| Earnings before taxes |
5,883
|
4,812
|
3,000 |
| Total assets |
47,987
|
104,804
|
47,668 |
| Current assets |
45,876
|
50,499
|
47,638 |
| Current liabilities |
29,046
|
29,290
|
27,971 |
| Equity capital |
18,729
|
65,777
|
19,295 |
| - share capital |
537
|
538
|
538 |
| Employees (average) |
150
|
150
|
150 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
39.0%
|
62.8%
|
40.5% |
| Turnover per employee |
681
|
1,409
|
657 |
| Profit as a percentage of turnover |
5.8%
|
2.3%
|
3.0% |
| Return on assets (ROA) | |||
| Current ratio |
157.9%
|
172.4%
|
170.3% |
| Return on equity (ROE) |
31.4%
|
7.3%
|
15.5% |
| Change turnover |
-108,649
|
112,736
|
4,166 |
| Change turnover % |
-52%
|
114%
|
4% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.